Senti Biosciences Files Q1 2025 10-Q
Ticker: SNTI · Form: 10-Q · Filed: May 6, 2025 · CIK: 1854270
Sentiment: neutral
Topics: 10-Q, biotech, financials
TL;DR
Senti Bio's Q1 2025 10-Q is in. Check financials for the latest.
AI Summary
Senti Biosciences, Inc. filed its quarterly report for the period ending March 31, 2025. The company, previously known as Dynamics Special Purpose Corp., is focused on biological products. Key financial data and operational details for the first quarter of 2025 are presented in this filing.
Why It Matters
This filing provides investors with an update on Senti Biosciences' financial health and operational status for the first quarter of 2025, crucial for understanding the company's trajectory in the biological products sector.
Risk Assessment
Risk Level: medium — As a company in the biological products sector, Senti Biosciences faces inherent risks related to research, development, regulatory approvals, and market adoption.
Key Players & Entities
- Senti Biosciences, Inc. (company) — Filer of the 10-Q report.
- Dynamics Special Purpose Corp. (company) — Former name of Senti Biosciences, Inc.
- 20250331 (date) — End of the reporting period for the 10-Q.
- 20250506 (date) — Filing date of the 10-Q.
FAQ
What is the primary business of Senti Biosciences, Inc.?
Senti Biosciences, Inc. is primarily involved in Biological Products (No Diagnostic Substances), as indicated by its SIC code [2836].
When did Senti Biosciences, Inc. change its name from Dynamics Special Purpose Corp.?
Senti Biosciences, Inc. changed its name from Dynamics Special Purpose Corp. on March 31, 2021.
What is the fiscal year end for Senti Biosciences, Inc.?
The fiscal year end for Senti Biosciences, Inc. is December 31.
What is the SEC file number for Senti Biosciences, Inc.?
The SEC file number for Senti Biosciences, Inc. is 001-40440.
What period does this 10-Q filing cover?
This 10-Q filing covers the period ending March 31, 2025.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 6, 2025 regarding Senti Biosciences, Inc. (SNTI).